Melinda Litherland Pei
Melinda Litherland Pei's purchase track record
Melinda Litherland Pei has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/5/2024 | RPID | $9K | +154.4% | +243.7% | -2.2% |
| 11/26/2024 | RPID | $32K | +168.6% | +238.1% | -1.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Bio‑Rad Leads in Recombinant Protein & Magnetic Bead Growth. The latest market report shows the recombinant protein manufacturing sector is expected to triple in revenue by 2030, with Bio‑Rad listed among the key players. A separate analysis projects the magnetic bead market to grow from $3.3 billion in 2025 to $7.4 billion by 2032, again naming Bio‑Rad as a leader. These developments highlight the company’s expanding role in both protein production and diagnostic reagent markets.
Transaction History
| RPID | ▲ Buy | Grant | 12,787 | $25K | 5/29/2026 | View on chart |
| RPID | ▲ Buy | Grant | 19,300 | $0 | 5/21/2026 | View on chart |
| BIO | ▲ Buy | Option Exercise | 407 | $0 | 4/21/2026 | View on chart |
| RPID | ▲ Buy | Grant | 14,300 | $0 | 5/22/2025 | View on chart |
| BIO | ▲ Buy | Option Exercise | 308 | $0 | 4/22/2025 | View on chart |
| RPID | ▲ Buy | Open Market | 9,120 | $9K | 12/5/2024 | View on chart |
| RPID | ▲ Buy | Open Market | 10,880 | $11K | 12/3/2024 | View on chart |
| RPID | ▲ Buy | Open Market | 19,892 | $21K | 11/27/2024 | View on chart |
| RPID | ▲ Buy | Open Market | 108 | $112 | 11/26/2024 | View on chart |
| RPID | ▲ Buy | Grant | 14,300 | $0 | 5/23/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
RPID Presents at Small-Cap Virtual Conference
Rapid Micro Biosystems presented at a small‑cap virtual conference, sharing updates on its product pipeline and business strategy. The event offered investors a chance to hear directly from management about recent progress and future plans. The presentation follows the company’s recent trading activity, with an RSI of 31.3 and support near $1.66.
RPID Presents at Small-Cap Virtual Conference. Rapid Micro Biosystems presented at a small‑cap virtual conference, sharing updates on its product pipeline and business strategy. The event offered investors a chance to hear directly from management about recent progress and future plans. The presentation follows the company’s recent trading activity, with an RSI of 31.3 and support near $1.66.